- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sonoma Pharmaceuticals Inc (SNOA)
Sonoma Pharmaceuticals Inc stock price live, this page displays NASDAQ SNOA stock exchange data. View the SNOA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sonoma Pharmaceuticals Inc real time stock price chart below.
What Is the Sonoma Pharmaceuticals Inc Stock Price Today?
The Sonoma Pharmaceuticals Inc stock price today is 3.085.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc?
The stock symbol for Sonoma Pharmaceuticals Inc is ""SNOA.""
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNOA quote. (ISIN: US83558L3033)
What Is the Sonoma Pharmaceuticals Inc Stock Price Today?
The Sonoma Pharmaceuticals Inc stock price today is 3.085.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc?
The stock symbol for Sonoma Pharmaceuticals Inc is ""SNOA.""
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNOA quote. (ISIN: US83558L3033)
NASDAQ
Currency in USD
3.085
+0.095(+3.18%)
Closed·
After Hours
3.171+0.086(+2.79%)
·
Fair Value
An estimate of a Sonoma Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.970
3.150
52 wk Range
1.750
6.400
SNOA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SNOA is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Sonoma Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.9703.150
52 wk Range
1.7506.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SNOA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sonoma Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
14.800
Upside
+379.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Sonoma Pharmaceuticals Inc Company Profile
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.
Compare SNOA to Peers and Sector
Metrics to compare | SNOA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNOAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −1.3x | −0.5x | |
PEG Ratio | −0.02 | −0.06 | 0.00 | |
Price/Book | 1.1x | 2.1x | 2.6x | |
Price / LTM Sales | 0.4x | 2.0x | 3.3x | |
Upside (Analyst Target) | 379.7% | 158.4% | 43.5% | |
Fair Value Upside | Unlock | 22.4% | 6.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.800
(+379.74% Upside)
Earnings
Latest Release
Jun 17, 2025
EPS / Forecast
-0.48 / -0.04
Revenue / Forecast
3.75M / 4.56M
People Also Watch
FAQ
What Stock Exchange Does Sonoma Pharma Trade On?
Sonoma Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Sonoma Pharma?
The stock symbol for Sonoma Pharma is "SNOA."
What Is the Sonoma Pharma Market Cap?
As of today, Sonoma Pharma market cap is 5.07M.
What Is Sonoma Pharma's Earnings Per Share (TTM)?
The Sonoma Pharma EPS (TTM) is -2.79.
From a Technical Analysis Perspective, Is SNOA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sonoma Pharma Stock Split?
Sonoma Pharma has split 4 times.
How Many Employees Does Sonoma Pharma Have?
Sonoma Pharma has 8 employees.
What is the current trading status of Sonoma Pharma (SNOA)?
As of 05 Aug 2025, Sonoma Pharma (SNOA) is trading at a price of 3.09, with a previous close of 3.09. The stock has fluctuated within a day range of 2.97 to 3.15, while its 52-week range spans from 1.75 to 6.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.